Portfolio Update

THE THROGMORTON TRUST PLC All information is at 31 October 2010 and unaudited. Performance at month end is calculated on a cum income basis One Three One Three Month Months Year Years Net asset value# 6.0% 22.3% 49.2% 12.7% Net asset value^ 6.0% 22.3% 49.4% 7.6% Net asset value^^ 5.1% 18.4% 40.3% 1.0% Share price 9.9% 19.8% 51.2% 8.1% Subscription share price 72.2% 200.0% n/a n/a HGSC plus AIM (ex Inv Cos) 3.6% 12.5% 23.4% -8.9% # NAV prior to costs of repaying the debentures early ^ NAV after costs of repaying the debentures early - undiluted ^^ NAV after costs of repaying debentures early - diluted Sources: BlackRock and Datastream At month end Net asset value capital only: 206.89p Net asset value incl. income: 209.54p Share price: 166.50p Discount to capital only NAV: 19.5% Subscription share price: 23.25p Net yield: 1.6% * Total assets: £129.3m ** Gearing: Nil Ordinary shares in issue: 58,367,192 *** Subscription shares in issue: 14,763,134 *Calculated using prior year interim and final dividends paid. **Includes current year revenue. ***Excluding 7,400,000 shares held in treasury. Ten Largest Sector Weightings % of Total Assets Software & Computer Services 10.3 Mining 10.1 Electronic & Electrical Equipment 9.5 Oil & Gas Producers 8.6 Support Services 7.8 Financial Services 7.2 Industrial Engineering 6.6 Media 4.8 Pharmaceutical & Biotechnology 4.5 Technology Hardware & Equipment 4.4 ---- Total 73.8 ==== Ten Largest Equity Investments (in alphabetical order)~ Company Abcam Aveva Group City of London Investment Group Domino Printing Sciences Eastern Platinum Fidessa Hutchison China Meditech IQE Spirax-Sarco Engineering Western Coal Commenting on the markets, Mike Prentis and Richard Plackett, representing the Investment Manager noted: During October the Company's NAV per share rose by 6.0% on a cum income basis; this was ahead of the benchmark which rose by 3.6%. The FTSE 100 Index rose by 2.3%. Our outperformance was mainly derived from stock selection but asset allocation also contributed to outperformance. The CFD portfolio again added value. From a stock point of view two holdings contributed more than 0.25% each to relative outperformance, Hutchison China Meditech and City of London Investment Group. Hutchison China Meditech had been our one poor performer in September. There was no newsflow in respect of the stock during September and October but the share price did make up for its weak performance in September. City of London Investment Group announced that assets under management had increased by 30% since its 31 May year end, helped by stronger emerging markets indices. It also moved its listing from AIM to the Official List. Pleasingly no one holding had a significant negative impact on the relative performance of the portfolio during the month. We sold our holding in Bluebay Asset Management following a bid by Royal Bank of Canada. Our holding in Bluebay had only been acquired in September, so we were very surprised to see a bid emerge. We also sold our holding in Intec Telecom which had received a bid from CSG of the US. We took new holdings in TT Electronics and New Britain Palm Oil. TT Electronics supplies sensors and other components mainly into automotive and industrial markets globally. New management have reshaped the business and are driving up margins from low levels. We feel the business is still undervalued; and it is trading well. New Britain Palm Oil is a significant producer of palm oil based in the Pacific. We had no previous exposure to soft commodities and with the palm oil price moving up sharply, as have many soft commodity prices, we felt it appropriate to make a small investment. Latest information is available by typing www.blackrock.co.uk/its on the internet, "BLRKINDEX" on Reuters, "BLRK" on Bloomberg or "8800" on Topic 3 (ICV terminal). 15 November 2010
UK 100

Latest directors dealings